Stephen Rocamboli Tff Pharmaceuticals, Inc. (TFFP) insider trading activity

Stephen Rocamboli is Director of TFF Pharmaceuticals, Inc.. Currently has a direct ownership of 39,165 shares of TFFP, which is worth approximately $97,912. The most recent transaction as insider was on Jul 03, 2024, when has been sold 3,165 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 39.2K

0% 3M change

8.79% 12M change

Total Value Held $97,912

STEPHEN ROCAMBOLI Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 03 2024	BUY Grant, award, or other acquisition	-	3,165 Added 7.48%	39,165 Common Stock
Aug 15 2023	BUY Open market or private purchase	$5,000 $0.25 p/Share	20,000 Added 35.71%	36,000 Common Stock
Mar 10 2023	BUY Open market or private purchase	$10,400 $0.8 p/Share	13,000 Added 44.83%	16,000 Common Stock
May 16 2022	BUY Open market or private purchase	$13,620 $4.54 p/Share	3,000 Added 13.81%	18,722 Common Stock
Mar 15 2021	SELL Open market or private sale	$337,101 $16.85 p/Share	20,006 Reduced 56.0%	15,722 Common Stock
Mar 15 2021	BUY Exercise of conversion of derivative security	$75,022 $3.75 p/Share	20,006 Added 35.9%	35,728 Common Stock
Nov 11 2020	SELL Open market or private sale	$247,779 $15.76 p/Share	15,722 Reduced 100.0%	0 Common Stock
Nov 11 2020	BUY Exercise of conversion of derivative security	$39,305 $2.5 p/Share	15,722 Added 50.0%	15,722 Common Stock
Nov 10 2020	SELL Open market or private sale	$322,149 $15.14 p/Share	21,278 Reduced 100.0%	0 Common Stock
Nov 10 2020	BUY Exercise of conversion of derivative security	$53,195 $2.5 p/Share	21,278 Added 50.0%	21,278 Common Stock

Also insider at

ESPR

Esperion Therapeutics, Inc. Healthcare

Director